- Feldman ED, Oppong BA, Willey SC. Breast cancer screening: clinical, radiologic, and biochemical. Clin Obstet Gynecol 2012;55 (3): 662–670.
- Tejerina Bernal A, Tejerina Bernal A, Rabadán Doreste F, De Lara González A, Roselló Llerena JA, Tejerina Gómez A. Breast imaging: how we manage diagnostic technology at a multidisciplinary breast center. J Oncol 2012;2012: 213421.
- Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, Weber W, Ziegler S, Graeff H, Schwaiger M. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18 (20): 3495–3502.
- Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology 2010;257 (1): 246–253.
- Springer A, Mawlawi OR. Evaluation of the quantitative accuracy of a commercially available positron emission mammography scanner. Med Phys 2011;38 (4): 2132–2139.
- Shkumat NA, Springer A, Walker CM, Rohren EM, Yang WT, Adrada BE, Arribas E, Carkaci S, Chuang HH, Santiago L, Mawlawi OR. Investigating the limit of detectability of a positron emission mammography device: a phantom study. Med Phys 2011;38 (9): 5176–5185.
- Kalinyak JE. Positron emission mammography: a new tool in the fight against breast cancer. Naviscan, Inc.
- Niklason LT, Kopans DB, Hamberg LM. Digital breast imaging: tomosynthesis and digital subtraction mammography. Breast Dis 1998;10 (3–4): 151–164.
- Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography: feature analysis and rates of malignancy. AJR Am J Roentgenol 2011;196 (4): 956–970.
- Wang CL, MacDonald LR, Rogers JV, Aravkin A, Haseley DR, Beatty JD. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG. AJR Am J Roentgenol 2011;197 (2): W247–W255.
- Eo JS, Chun IK, Paeng JC, Kang KW, Lee SM, Han W, Noh DY, Chung JK, Lee DS. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. Breast 2012;21 (1): 66–71.
- Schilling K, Narayanan D, Kalinyak JE, The J, Velasquez MV, Kahn S, Saady M, Mahal R, Chrystal L. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2011;38 (1): 23–36.
- Berg WA, Madsen KS, Schilling K, Tartar M, Pisano ED, Larsen LH, Narayanan D, Ozonoff A, Miller JP, Kalinyak JE. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology 2011;258 (1): 59–72.
- Berg WA, Madsen KS, Schilling K, Tartar M, Pisano ED, Larsen LH, Narayanan D, Kalinyak JE. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. AJR Am J Roentgenol 2012;198 (1): 219–232.
- Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility. AJR Am J Roentgenol 2011;196 (4): 971–981.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 26, 2013 - Issue 3